Curi Bio Names Nicholas Geisse, Ph.D., as New Chief Executive Officer

Portfolio Company Curi Bio recently announce the new appointment of Nicholas (Nick) Geisse, Ph.D. as CEO to lead the organization. Dr. Geisse has been serving as the Chief Science Officer at Curi Bio since 2017. During that time, he was responsible for guiding the company’s scientific strategy and the commercialization of its next-generation products that greatly improve the predictive power of in vitro cell-based assays. Dr. Geisse succeeds Michael Cho, J.D., who will continue on with the company in a role focusing on corporate strategy and legal matters.